期刊文献+

HR-CT鉴别结节性甲状腺肿与微小甲状腺乳头状瘤的价值

Value of HR-CT in the Differential Diagnosis of Nodular Goiter and Papillary Thyroid Microcarcinoma
下载PDF
导出
摘要 目的探讨高分辨计算机断层扫描(HR-CT)鉴别结节性甲状腺肿(NG)与微小甲状腺乳头状瘤(PTMC)的价值。方法回顾性选取2019年5月-2022年6月收治的76例NG患者(NG组)和82例PTMC患者(PTMC组)作为研究对象,两组均行HR-CT,分析HR-CT在鉴别结节性甲状腺肿与微小甲状腺乳头状瘤的价值。结果HR-CT对NG和PTMC诊断的符合率为分别为97.37%,90.24%,两组符合率比较差异无统计学意义(P>0.05);NG组和PTMC组在瘤体形态、结节数、增强后边界情况、细颗粒状钙化、边缘中断症、假包膜方面差异具有统计学意义(P<0.05);多因素回归显示,瘤体形态、增强后边界、边缘中断症、假包膜均为NG和PTMC的独立影响因素(P<0.05)。结论HR-CT在NG与PTMC的鉴别诊断方面具有重要价值,临床可根据瘤体形态、增强后边界、边缘中断症、假包膜辅助鉴别诊断。 Objective To explore the value of high-resolution computed tomography(HR-CT)in the differential diagnosis of nodular goiter(NG)and papillary thyroid microcarcinoma(PTMC).Methods A total of 76 patients with NG(NG group)and 82 patients with PTMC(PTMC group)were retrospectively enrolled as the research objects between May 2019 and June 2022.All underwent HR-CT.The value of HR-CT in the differential diagnosis of NG and PTMC was analyzed.Results The coincidence rates of HR-CT in the diagnosis of NG and PTMC were 97.37%and 90.24%,and the difference was not statistically significant(P>0.05).The differences in tumor morphology,number of nodules,borders after enhancement,fine granular calcification,edge disruption and pseudocapsule between the two groups were statistically significant(P<0.05).Multivariate regression analysis showed that tumor morphology,borders after enhancement,edge disruption and pseudocapsule were independent influencing factors of NG and PTMC(P<0.05).Conclusion HR-CT is of great value in the differential diagnosis of NG and PTMC.Clinically,tumor morphology,borders after enhancement,edge disruption and pseudocapsule can be applied in the differential diagnosis.
作者 李雪菲 王桂东 李劲浩 杨扬 LI Xue-fei;WANG Gui-dong;LI Jing-hao;YANG Yang(CT/MRI Room of Handan First Hospital,Handan 056002,Hebei Province,China)
出处 《中国CT和MRI杂志》 2023年第6期41-43,共3页 Chinese Journal of CT and MRI
基金 邯郸市科学技术研究与发展计划项目(19422083010-24)。
关键词 高分辨计算机断层扫描 结节性甲状腺肿 微小甲状腺乳头状瘤 High-Resolution Computed Tomography Nodular Goiter Papillary Thyroid Microcarcinoma
  • 相关文献

参考文献16

二级参考文献190

  • 1王琳.彩色多普勒超声对甲状腺良恶性肿瘤的鉴别诊断价值[J].世界临床医学,2017,11(5):219-219. 被引量:3
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 3Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 4Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 5Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 6De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 7Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 8Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 9Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 10Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.

共引文献577

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部